Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Cage Rattler who wrote (621)	10/24/1998 11:38:00 AM
From: DavidCG	Read Replies (2) \| Respond to of 1255

I love it... I was just wondering when the Bre-X banner was going to be brought around. Any stock that falls after a trader buys is automatically a Bre-X candidate. Give me a break. So now you've gone full circle from thinking CORX didn't get good reporting by NBC to thinking CORX is now a complete fraud. Bravo! That's right, the highly respected National Institutes of Health (run by the US Government), two independent universities, NBC and ABC news, are involved in a fraud to bilk you, Mr. Parker, out of all your hard earned cash. It's Cortexgate! Run for your lives, its BRE-X ALL OVER! SELL SELL! Hang the ring leader of this conspiracy: TOM BROKAW! OH THE HUMANITY! You're a genious! Excellent detective work. You're a regular Columbo. Also, interesting you mention "CORX's lack of corporate to stock-holder communication". We just had a news release yesterday (Friday). Maybe you should read it. News releases are communication. And, the message from a female Yahoo poster about 4 messages back spoke to the CEO of CORX for an entire hour. So, I guess, in your mind, the CEO isn't communicating because he isn't looking up your name in the phone book and placing a call to you. Maybe it should be you that places a call and stop whining that you aren't getting exactly what you want in the time frame you desire. Don't send some other investor to do your leg work because you are too lazy to pick up a phone. To Cavalry... please get your facts straight. NEOT is testing on humans... in Phase II testing. Please, AT LEAST read NEOT's news releases before making inaccurate statements. That, and the fact their float is a lot smaller than CORX's explains the rise in price. -DavidCG

To: Cage Rattler who wrote (621)	10/24/1998 12:17:00 PM
From: Cavalry	Respond to of 1255

someone post the address of corx for me, thanks.. This is learning experience for me, will ride by and report to thread, not trying to hype another stock here, but what really strikes me is the huge differences between HEB and CORX, the contrasts are telling sign for me.... 1 heb 326 patents corx 5 2 heb phase 3, orphan status as well as cost recovery status, corx conflicting info raging about as to status of research, p1 or p2, rats only or human testing as well, nbc piece coupled with lack of clarity from ir adding to this confusion. remember confusion creates doubt, doubt creates fear, fear creates panic, panic creates a sell-off, corx's failure to disseminate accurate and timely shareholder updates has hurt this stock value. 3 heb only potential cure for cfs, corx maybe one of many potential cures for altzheimers 4 heb almost daily press releases as well as constantly updated website, corx ir woman who tells nothing to investors for over 2 years 5 heb manufacturing(company in south africa) in place, corx doesnt address this issue anywhere 6 heb aligned with quality names like olsten, corx going it alone 7 heb has no rivals, corx has neot hot on its heels a drug needs to have desperate potential users exerting massive pressure on fda to get the approval process moving at normal speed, who is going to fight for altzheimers cure, assisted living facilities whose future depends on no cure for altz, the people with altzheimers, the children whose life is burdened with elder care, the only one who cares are people selling long term care policies which have altzheimers as a benefit trigger, not life and death no pressure on fda to speed up corx's approval status, this is what's killing corx, imo. people are spending every dime they have in the world to get ampligen in cost recovery tests, without ampligen they have no hope, 86% have renewed their enrollment after first 24 weeks, telling sign to me. cav